These results indicate Drd2 and β-arrestin2 participate in the pathogenesis of MDD and genetic deletion of β-arrestin2 enlarges the neuroinflammatory signs and astrocytic loss induced by CUMS mouse model. Here, DRD2 is linked to major depressive disorder.